TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Researchers at the University Hospital of Bonn and the University of Bonn directly reprogrammed human red blood cell precursors into neural stem cells in the laboratory. The cells’ epigenetic clocks shifted to younger readings, including a reported reading below 20 years for cells from an 80-year-old donor; the work does not show rejuvenation in people or a treatment for age-related disease.
Researchers at the University Hospital of Bonn and the University of Bonn have converted human red blood cell precursors directly into neural stem cells in laboratory experiments, finding that the cells’ epigenetic age markers shifted to much younger readings. The result, published in Aging Cell, offers researchers a way to study how cellular age changes during reprogramming; it is not evidence that the process rejuvenates people or treats disease.
The team used a combination of transcription factors to redirect blood-cell precursors toward a neural stem-cell identity, without first turning them into pluripotent stem cells. Neural stem cells can give rise to brain-cell types. The report describes this as a direct conversion carried out in a laboratory, rather than a procedure performed in a person.
To estimate cell age, researchers examined epigenetic clocks, which track patterns of DNA modification associated with aging. These modifications affect how genetic information is read, rather than changing the underlying DNA sequence. The researchers reported that the clocks were reset during conversion. Cells from an 80-year-old donor showed a measured molecular age of less than 20 years.
Unlike a previously described two-step method, in which cells first become pluripotent stem cells and are then directed toward a neural fate, the Bonn approach produced a gradual change over weeks. The team followed the process for more than 100 days, and reported that one example involved a roughly 60-year shift after 50 days. The paper is titled “Protracted Fate Acquisition and Epigenetic De-Aging During Induced Neural Stem Cell Conversion of Human Blood Cells.”
A Slow Model for Cellular Aging
The main significance is experimental: a process that unfolds over an extended period gives scientists an opportunity to examine when and how epigenetic age markers change as a cell adopts a new identity. The researchers say the model could help test which factors or substances speed up or slow down those changes. That may help clarify whether age-related molecular changes are linked to a cell’s function, though this study does not establish a clinical benefit.
The work is relevant to neuroscience because aging is a major risk factor for neurodegenerative diseases, including Alzheimer’s, as Bonn professor Oliver Brüstle noted. But the study does not report a treatment for Alzheimer’s or show that the reprogrammed cells can reverse aging in the brain. Its immediate value is as a laboratory research tool, not a therapy.
As an affiliate, we earn on qualifying purchases.
Direct Conversion Versus Two Steps
Cells in the body share the same genetic makeup but acquire different functions as they develop. A mature blood cell does not naturally become a neuron. In laboratory reprogramming, researchers use transcription factors to change which genetic instructions a cell follows, directing it toward another cell type.
Earlier work on reprogramming had found rejuvenation during a two-stage process that passes through a pluripotent stem-cell state. Bonn’s reported method instead converts blood-cell precursors directly into neural stem cells. The researchers say the slower clock reset makes it possible to follow the process over time. The results are reported by Berg and colleagues in the journal Aging Cell, DOI 10.1111/acel.70751.
““In contrast, we converted blood cells directly into neural stem cells—that is, without first passing through the pluripotent cell stage.””
— Prof. Oliver Brüstle, director of the Institute of Reconstructive Neurobiology at the University Hospital of Bonn
DNA methylation epigenetic testing kit
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Limits of the Age Readings
The reported ages refer to molecular measurements in laboratory-grown cells, not a person’s biological age, lifespan or health. The source report does not provide enough detail to determine how broadly the age readings apply across donors, cell samples or experimental conditions. It also does not establish whether the changes persist after conversion or how the cells perform over longer periods.
The findings do not show that the method is safe or effective as a therapy, and no clinical use is reported. The team’s observation that epigenetic rejuvenation can coincide with cells behaving like younger cells is a research claim; the supplied report does not detail the functional tests behind that statement. Whether the approach could eventually support studies or treatments for neurodegenerative disease remains open.
cell reprogramming laboratory tools
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Testing What Changes the Clock
The next research step identified by Brüstle is to use the slow conversion process to investigate which factors and active substances affect the rate of rejuvenation. Tracking clock changes across the conversion period could help researchers identify stages at which the cells’ molecular profiles shift.
The supplied report does not announce a clinical trial or a timeline for medical applications. Further work would be needed to test how reproducible the findings are, what drives the measured changes and whether they have lasting functional effects. For now, the Bonn study presents a laboratory model for examining cellular reprogramming and age-associated molecular markers.
As an affiliate, we earn on qualifying purchases.
Key Questions
What did the Bonn researchers do?
They used transcription factors to convert human red blood cell precursors directly into neural stem cells in a laboratory, then measured changes in epigenetic age markers.
What does a molecular age below 20 mean?
The researchers reported that cells from an 80-year-old donor had an epigenetic clock reading below 20 years after reprogramming. This is a molecular measurement, not evidence that the donor or their body became younger.
Does the study offer a treatment for Alzheimer’s?
No. The study describes a laboratory method for studying cell conversion and age markers. It does not report a treatment or clinical trial for Alzheimer’s or another neurodegenerative disease.
Why is the slow conversion process useful?
The researchers say its gradual pace, tracked for more than 100 days, lets them examine how epigenetic clocks change over time and investigate factors that may affect the process.
Source: rss
Fall Picks
fall essentials
As an affiliate, we earn on qualifying purchases.
